TodayLegal News

Verdict.News

All Topics

Fda Regulation

Legal news related to Fda Regulation

5 articles

Regulatory
•4 min read

FDA Announces Voluntary Recall of Sea Moss Gel Products Over Violations

Los Angeles-based Diva Fam Inc. announced a voluntary recall of all lots and flavors of its Sea Moss Gel Superfood products on Jan. 9, 2025, due to lack of required FDA regulatory authorization and missing temperature monitoring records for pH-controlled food products.

•Complete voluntary recall of all Sea Moss Gel Superfood products by Diva Fam Inc.
•Recall triggered by missing FDA regulatory authorization and temperature monitoring violations
AI-generated SummaryRead Article →
Regulatory
•4 min read

FDA Announces Recall of Indian Sweets Over Undeclared Milk Allergen

Karison Foods & Snacks Inc has recalled five traditional South Asian sweet products due to undeclared milk allergens. The FDA-announced recall affects 12-ounce containers of popular items including Panjiri, Alsi Pinni, Punjabi Pinni, and Besan Laddoo varieties.

•Five traditional South Asian sweet products recalled for undeclared milk allergen
•Products distributed by Port Washington, NY-based Karison Foods & Snacks Inc
AI-generated SummaryRead Article →
Regulatory
•4 min read

FDA Issues Recall Warning for Modern Warrior Supplement With Hidden Drugs

Modern Warrior voluntarily recalled all lots of its 'Modern Warrior Ready' dietary supplement after FDA testing revealed undeclared ingredients including tianeptine, 1,4-DMAA, and aniracetam. The recall affects products sold directly to consumers and highlights ongoing concerns about unapproved substances in dietary supplements.

•Modern Warrior recalled all lots of Modern Warrior Ready supplement on Dec. 22, 2025, after FDA found undeclared ingredients
•Testing identified tianeptine, 1,4-DMAA, and aniracetam - substances not approved for dietary supplement use
AI-generated SummaryRead Article →
Regulatory
•4 min read

FDA Approves First Gene Therapy for Wiskott-Aldrich Syndrome

The FDA has approved Waskyra (etuvetidigene autotemcel), marking the first cell-based gene therapy treatment for Wiskott-Aldrich syndrome. This approval represents a significant milestone in treating the rare genetic immune disorder.

•FDA approves Waskyra as first cell-based gene therapy for Wiskott-Aldrich syndrome
•Treatment addresses rare X-linked immunodeficiency disorder primarily affecting males
AI-generated SummaryRead Article →
Regulatory
•4 min read

FDA Conditionally Approves First Topical Treatment for Deadly Cattle Parasites

The FDA has conditionally approved Exzolt Cattle-CA1, a fluralaner-based topical solution for preventing and treating New World screwworm larvae and controlling cattle fever ticks in beef cattle. This regulatory approval represents a significant advancement in veterinary medicine for addressing serious parasitic threats that can devastate livestock populations.

•FDA conditionally approved Exzolt Cattle-CA1 topical solution containing fluralaner for cattle parasites
•Treatment targets New World screwworm larvae prevention/treatment and cattle fever tick control
AI-generated SummaryRead Article →